Literature DB >> 21607092

The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.

Mi-La Kim1, Ho-Suap Hahn, Kyung-Taek Lim, Ki-Heon Lee, Hy-Sook Kim, Sung-Ran Hong, Tae-Jin Kim.   

Abstract

OBJECTIVE: To evaluate the occurrence of residual or recurrent disease after conization for adenocarcinoma in situ (AIS) of the uterine cervix.
METHODS: Medical records of 99 patients with a histologically diagnosis of AIS of the uterine cervix by conization between 1991 and 2008 were reviewed retrospectively.
RESULTS: Seventy eight of 99 patients (78.8%) had negative and 18 (18.2%) had positive resection margins of the conization specimen, and 3 (3.0%) had unknown margin status. Of the 78 patients with negative margins, 45 underwent subsequent hysterectomy and residual AIS were present in 4.4% (2/45) of patients. Ten of the 18 patients with positive margins received subsequent hysterectomy and 3 patients (30%) had residual AIS. Twenty-eight patients had conservative treatment and during the median follow-up time of 23.5 months (range, 7 to 124 months), only one patient (3.6%) had recurrent AIS and was treated with a simple hysterectomy. Eight patients became pregnant after conization, 4 of them delivered healthy babies, one had a spontaneous abortion and 3 were ongoing pregnancies.
CONCLUSION: Patients with positive resection margins after conization for AIS of the uterine cervix are significantly more likely to have residual disease. However, negative resection margin carries a lower risk for residual AIS, therefore conservative management with careful surveillance seems to be feasible in women who wish to preserve their fertility.

Entities:  

Keywords:  Adenocarcinoma in situ; Conization; Conservative treatment; Uterine cervix cancer

Year:  2011        PMID: 21607092      PMCID: PMC3097330          DOI: 10.3802/jgo.2011.22.1.25

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  23 in total

1.  Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment.

Authors:  Erik Soegaard Andersen; Karsten Nielsen
Journal:  Gynecol Oncol       Date:  2002-09       Impact factor: 5.482

2.  Further study of the management of cervical adenocarcinoma in situ.

Authors:  Alexander W Kennedy; Charles V Biscotti
Journal:  Gynecol Oncol       Date:  2002-09       Impact factor: 5.482

3.  Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.

Authors:  M M Madeleine; J R Daling; S M Schwartz; K Shera; B McKnight; J J Carter; G C Wipf; C W Critchlow; J K McDougall; P Porter; D A Galloway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-03       Impact factor: 4.254

4.  Cold-knife conization versus loop excision: histopathologic and clinical results of a randomized trial.

Authors:  F Girardi; M Heydarfadai; F Koroschetz; H Pickel; R Winter
Journal:  Gynecol Oncol       Date:  1994-12       Impact factor: 5.482

5.  Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Authors:  A G Ostör; A Duncan; M Quinn; R Rome
Journal:  Gynecol Oncol       Date:  2000-11       Impact factor: 5.482

6.  Randomized study comparing two techniques of conization: cold knife versus loop excision.

Authors:  P L Giacalone; F Laffargue; N Aligier; P Roger; J Combecal; J P Daures
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

7.  Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.

Authors:  M T McHale; T D Le; R A Burger; M Gu; J L Rutgers; B J Monk
Journal:  Obstet Gynecol       Date:  2001-11       Impact factor: 7.661

8.  Is conservative treatment for adenocarcinoma in situ of the cervix safe?

Authors:  W P Soutter; D Haidopoulos; R J Gornall; G A McIndoe; J Fox; W P Mason; A Flanagan; N Nicholas; F Barker; J Abrahams; I Lampert; P Sarhanis
Journal:  BJOG       Date:  2001-11       Impact factor: 6.531

9.  Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.

Authors:  Silvano Costa; Giovanni Negri; Mario Sideri; Donatella Santini; Giuseppe Martinelli; Simona Venturoli; Carla Pelusi; Stina Syrjanen; Kari Syrjanen; Giuseppe Pelusi
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

10.  Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure.

Authors:  T C Wright; S Gagnon; R M Richart; A Ferenczy
Journal:  Obstet Gynecol       Date:  1992-02       Impact factor: 7.661

View more
  4 in total

1.  Cervical adenocarcinoma in situ with negative conization margin: negligible or not?

Authors:  Sokbom Kang
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

2.  Cytological variations and typical diagnostic features of endocervical adenocarcinoma in situ: A retrospective study of 74 cases.

Authors:  Takashi Umezawa; Miyaka Umemori; Ayana Horiguchi; Kouichi Nomura; Hiroyuki Takahashi; Kyosuke Yamada; Kazunori Ochiai; Aikou Okamoto; Masahiro Ikegami; Motoji Sawabe
Journal:  Cytojournal       Date:  2015-04-29       Impact factor: 2.091

Review 3.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

4.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.